News for AIM ImmunoTech Inc. (HXB2.F)

OCALA, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that Thomas K. Equels, Chief Executive Officer of AIM

4 Biotech Penny Stocks to Watch Right Now Over the past twelve months, interest in biotech penny stocks has continued to see new peaks. While this is partly du...

AIM ImmunoTech Announces the Expansion of its Pancreatic Cancer Program to Include New Patients in the Netherlands Early Access Program Will Also Allow Further Treatment of Patients Treated Under the Previous Ampligen Early Access Program GlobeNewswire February 10, 2021 OCALA, Fla., Feb. 10, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American:...

AIM ImmunoTech Completes and Closes ATM Facility; Current Capital Expected to Meet Needs for Current Clinical Trials GlobeNewswire February 05, 2021 OCALA, Fla., Feb. 05, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has completed its At-The-Market (ATM) facility and closed the ATM’s Equity Distribution Agreement...

OCALA, Fla., Feb. 05, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has completed its At-The-Market (ATM) facility

Should You Buy These Cheap Penny Stocks? The definition of the term “penny stocks” refers to stocks trading for less than $5. This is according to the Secu...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 28) ...

OCALA, Fla., Jan. 15, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) today announced that it has rescheduled its investor conference call for 11:00 ...

OCALA, Fla., Jan. 11, 2021 -- AIM ImmunoTech Inc. and its CEO Thomas K. Equels today announced that this week’s planned investor conference call will be postponed and rescheduled for... | January 11, 2021